EZH2 and hepatocellular carcinoma: Additionally, the upregulation of tumor suppressor deleted in liver cancer 1 (DLC1) and four and a half LIM domains 1 (FHL1) by DZNep, an EZH2-specific inhibitor, also suppressed the proliferation and migration of HCC cell lines [80,81].